CYP3A4 and posterior cortical atrophy: Transactivation studies indicate that the -290A/G variant results in an increase in reporter gene activity, suggesting that the CYP3A4*1B polymorphism is unlikely to decrease the capacity to inactivate testosterone and therefore increase the risk for PCa development [26], [27].